ผลงานหน่วยวิชาโลหิตวิทยา
1. ประชุมวิชาการ
– จัดประชุมวิชาการประจำปี Chiang Mai Hematology Conference (CHC) โดยมีผู้เข้าร่วมประชุมทั้งจากภายในและภายนอกคณะฯ จำนวนประมาณ 200 คน เป็นประจำทุกปี ติดต่อกันมาตั้งแต่ปี พ.ศ. 2552
– จัดสัมมนาให้ความรู้ประชาชน แก่ผู้ป่วยและผู้สนใจเป็นประจำทุกปี โดยมีผู้สนใจประมาณ 50-80 คน
2. งานวิจัย
1. Seresirikachorn K. , Ausayakhun S. , Wiwatwongwana D. , Mahanupab P. , DaroontumT. , Norasetthada L. Characteristics and treatment outcomes of patients with primary ocular adnexal lymphoma in northern Thailand (https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85078354874&origin=inward) Asian Journal of Ophthalmology. 17:86-97. 2020 JDA
2. Koonarat A. , Rattarittamrong E. , Tantiworawit A. , Rattanathammethee T. ,Hantrakool S. , Chai-Adisaksopha C. , Norasetthada L. Clinical characteristics, risk factors, and outcomes of usual and unusual site venous thromboembolism (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85041472411&origin=inward) Blood Coagulation and Fibrinolysis. 29:12-18. 2018 JIF : 1.367 citedby-count: 1
3. Seresirikachorn K. , Norasetthada L. , Ausayakhun S. , Apivatthakakul A. ,Tangchittam S. , Pruksakorn V. , Wudhikarn K. , Wiwatwongwana D. Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85058627367&origin=inward) Blood Research. 53:307-313. 2018 JDA
4. Hengjeerajarus N. , Klaisuwan T. , Norasetthada L. , Kosachunhanun N. Mucosa-associated lymphoid tissue lymphoma with large cell transformation on the background of hashimoto’s thyroiditis: A case report and review literature(https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84929628668&origin=inward) Journal of the Medical Association of Thailand. 98:514-519. 2015 citedby-count: 5
5. Intragumtornchai T. , Bunworasate U. , Siritanaratkul N. , Khuhapinant A. ,Nawarawong W. , Norasetthada L. , Lekhakula A. , Rujirojindakul P. , Sirijerachai C. ,Chansung K. , Suwanban T. , Chuncharunee S. , Niparuck P. , Wongkhantee S. ,Mongkonsritragoon W. , Numbenjapon T. Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessibility (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84870893023&origin=inward) Leukemia and Lymphoma. 54:83-89. 2013 JIF : 2.580 citedby-count: 9
6. Wongcharoen W. , Pacharasupa P. , Norasetthada L. , Gunaparn S. , Phrommintikul A. Anti-Factor Xa Activity of Standard and Japan-Specific Doses of Rivaroxaban in Thai Patients With Non-Valvular Atrial Fibrillation (https://www.ncbi.nlm.nih.gov/pubmed/32461505) Circulation journal. . 2020 JIF : 3.025
7. Ampasavate C. , Jutapakdee W. , Phongpradist R. , Tima S. , Tantiworawit A. ,Charoenkwan P. , Chinwong D. , Anuchapreeda S. FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85065971444&origin=inward) Journal of Clinical Laboratory Analysis. 33. 2019 JIF : 1.303 JDA
8. Tantiworawit A. , Rattanathammethee T. , Chai-Adisaksopha C. , Rattarittamrong E. ,Norasetthada L. Outcomes of adult acute lymphoblastic leukemia in the era of pediatric-inspired regimens: a single-center experience (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85066848715&origin=inward) International Journal of Hematology. . 2019 JIF : 1.942
9. Owattanapanich W. , Utchariyaprasit E. , Tantiworawit A. , Rattarittamrong E. ,Niparuck P. , Puavilai T. , Julamanee J. , Saelue P. , Chanswangphuwana C. ,Polprasert C. , Limvorapitak W. , Kanitsap N. , Wanitpongpun C. , Nakhakes C. ,Sriswasdi C. , Prayongratana K. Improved Survival of Elderly-t Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From
TALWG (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85053010803&origin=inward) Clinical Lymphoma, Myeloma and Leukemia. 18:e509-e514. 2018 citedby-count: 2
10. Pattanakuhar S. , Phrommintikul A. , Tantiworawit A. , Konginn S. , SrichairattanakoolS. , Chattipakorn S. , Chattipakorn N. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85041567136&origin=inward) Bioscience Reports. 38. 2018 JIF : 2.906 JDA
11. Mevatee P. , Tantiworawit A. , Traisathit P. , Puaninta C. , Mevatee U. , AngsuchawanS. , Bumroongkit K. FLT3-ITD, NPM1, and DNMT3A gene mutations and risk factors in normal karyotype acute myeloid leukemia and myelodysplastic syndrome patients in upper Northern Thailand
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85035075730&origin=inward) Asian Pacic Journal of Cancer Prevention. 18:3031-3039. 2017 JDA
12. Nanthakwang N. , Rattarittamrong E. , Rattanathammethee T. , Chai-Adisaksopha C. ,Tantiworawit A. , Norrasethada L. , Ya-In C. Clinicopathological study and outcomes of primary extranodal lymphoma
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85076617576&origin=inward) Hematology Reports. 11:79-83. 2019
13. Rattarittamrong E. , Tantiworawit A. , Kumpunya N. , Wongtagan O. , Tongphung R. ,Phusua A. , Chai-Adisaksopha C. , Hantrakool S. , Rattanathammethee T. ,Norasetthada L. , Charoenkwan P. , Lekawanvijit S. Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85043317270&origin=inward) Hematology. 23:613- 619. 2018 JIF : 1.244 JDA
14. Rattarittamrong E. , Norasetthada L. , Tantiworawit A. , Chai-Adisaksopha C. ,Nawarawong W. CHOEP-21 chemotherapy for newly diagnosed nodal peripheral T-cell lymphomas (PTCLs) in Maharaj Nakorn Chiang Mai Hospital (https://www.ncbi.nlm.nih.gov/pubmed/24428090) Journal of the Medical
Association of Thailand = Chotmaihet thangphaet. 96:1416-22. 2013 citedby-count: 1 JDA
15. Patpan N. , Banjerdpongchai R. , Tantiworawit A. , Poofery J. , Komonrit P. ,Fanhchaksai K. , Rattanathammethee T. , Chai-Adisaksopha C. , Rattarittamrong E. ,Norasetthada L. , Charoenkwan P. The Effect of Transfusion-DependentThalassemia Patient’s Serum on Peripheral Blood Mononuclear Cell Viability
(https://www.ncbi.nlm.nih.gov/pubmed/30670921) Journal of cell death.12:1179066018823534. 2019 JDA
16. Makmettakul S. , Tantiworawit A. , Lekawanvijit S. , Phrommintikul A. ,Rattanathammethee T. , Hantrakool S. , Chai-Adisaksopha C. , Rattarittamrong E. ,Norasetthada L. Cardiorenal Syndrome in Thalassemia Patients BLOOD. 130.2017 JIF : 11.847 JDA
17. Norasetthada L. , Tantiworawit A. , Rattanathammethee T. , Hantrakool S. ,ChaiAdisaksopha C. , Rattarittamrong E. EFFICACY OF ESHAP REGIMEN IN THE ABSENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY T-CELL LYMPHOMA HAEMATOLOGICA. 101:696-696. 2016 JIF : 5.814
18. Warit W. , Norasetthada L. , Tantiworawit A. , Rattarittamrong E. , Chaiadisaksopha C., Hantrakool S. , Ornkamon W. , Nawarawong W. High Prevalence of Platelet Dysfunction Among Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors BLOOD. 124. 2014 JIF : 9.060 citedby-count: 1 JDA
19. Hantrakool S. , Tantiworawit A. , Rattarittamrong E. , Chai-adisaksopa C. ,Nawarawong W. , Srichairattanakool S. , Phornphutkul M. , Norasetthada L. ElevatedSerum Ferritin Levels Are Highly Associated with Diabetes Mellitus and Hypothyroidism in Thalassemia Patients BLOOD. 120. 2012 JIF : 10.558 citedby-count: 4 JDA
20. Limvorapitak W. , Owattanapanich W. , Utchariyaprasit E. , Niparuck P. , Puavilai T. ,Tantiworawit A. , Rattanathammethee T. , Saengboon S. , Sriswasdi C. , Julamanee J., Saelue P. , Polprasert C. , Wudhikarn K. , Wanitpongpun C. , Prayongratana K. Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia – A multicenter prospective registry in Thai population
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85074031507&origin=inward) Leukemia Research. 87. 2019 JIF : 2.319
21. Polprasert C. , Takeda J. , Niparuck P. , Rattanathammethee T. , Pirunsarn A. ,Suksusut A. , Kobbuaklee S. , Wudhikarn K. , Lawasut P. , Kongkiatkamon S. ,Chuncharunee S. , Songserm K. , Phowthongkum P. , Bunworasate U. , Nannya Y. ,Yoshida K. , Makishima H. , Ogawa S. , Rojnuckarin P. Novel DDX41 variants in Thai patients with myeloid neoplasms (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85075040765&origin=inward) International Journal of Hematology. . 2019 JIF : 1.942 AOI
22. Rattanathammethee T. , Tantiworawit A. , Rattarittamrong E. , Chai-Adisaksopha C. ,Hantrakool S. , Phrommintikul A. , Wongcharoen W. , Gunaparn S. , Norasetthada L. Peripheral Artery Occlusive Disease Among Patients With Chronic MyeloidLeukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-ControlStudy (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85044630066&origin=inward) Clinical Medicine Insights: Cardiology. 11. 2017 citedby-count: 1
23. Phrommin S. , Tantiworawit A. , Rattanathammethee T. , Puaninta C. , Pangjaidee N. ,Aungsuchawan S. , Bumroongkit K. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand (https://www.ncbi.nlm.nih.gov/pubmed/32212788) Asian Pacic journal of cancer prevention : APJCP. 21:639-645. 2020 JDA
24. Rattanathammethee T. , Tantiworawit A. , Rattarittamrong E. , Chai-Adisaksopha C. ,Hantrakool S. , Phrommintikul A. , Gunaparn S. , Norasetthada L. High Prevalence of Peripheral Artery Occlusive Disease (PAOD) Among Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors (TKIs): A Cross-Sectional Study BLOOD. 126. 2015 JIF : 9.775
25. Piriyakhuntorn P. , Tantiworawit A. , Rattanathammethee T. , Chai-Adisaksopha C. ,Rattarittamrong E. , Norasetthada L. The role of red cell distribution width in the differential diagnosis of iron deciency anemia and non-transfusion dependent thalassemia patients (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85053142262&origin=inward) Hematology Reports. 10:72-76. 2018
26. Piriyakhuntorn P. , Tantiworawit A. , Phimphilai M. , Srichairatanakool S. ,Teeyasoontranon W. , Rattanathammethee T. , Chai-Adisaksopha C. , Rattarittamrong E. , Norasetthada L. , Charoenkwan P. Prevalence and Risk Factors of Low Bone Mineral Density and Fractures of Young Thalassemia Patients BLOOD. 132.2018 JIF : 13.164 JDA
27. Wudhikarn K. , Bunworasate U. , Julamanee J. , Lekhakula A. , Ekwattanakit S. ,Khuhapinant A. , Chuncharunee S. , Niparuck P. , Numbenjapon T. , Prayongratana K. ,Kanitsap N. , Wongkhantee S. , Makruasi N. , Wong P. , Norasetthada L. , Nawarawong W. , Sirijerachai C. , Chansung K. , Suwanban T. , Praditsuktavorn P. ,Intragumtornchai T. Characteristics, treatment patterns, prognostic determinants
and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85063582476&origin=inward) Journal of Geriatric Oncology. . 2019 JIF : 3.359
28. Wudhikarn K. , Bunworasate U. , Julamanee J. , Lekhakula A. , Ekwattanakit S. ,Khuhapinant A. , Niparuck P. , Chuncharunee S. , Numbenjapon T. , Prayongratana K. ,Kanitsap N. , Wongkhantee S. , Makruasri N. , Wong P. , Norasetthada L. ,Nawarawong W. , Sirijerachai C. , Chansung K. , Suwanban T. , Praditsuktavorn P. ,Intragumtornchai T. Event free survival at 24 months is a strong surrogate
prognostic endpoint of peripheral T cell lymphoma (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85075039642&origin=inward) Hematological Oncology. . 2019 JIF : 3.193
29. Natesirinilkul R. , Charoenkwan P. , Nawarawong W. , Boonsri S. , Tantivate P. ,Wongjaikum S. , Manowong S. , Sanguansermsri T. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84960334058&origin=inward) Thrombosis Research. 140:125-131. 2016 JIF : 2.447 citedby-count: 4 JDA
30. Chueamuangphan N. , Patumanond J. , Wongtheptien W. , Nawarawong W. ,Sukonthasarn A. , Chuncharunee S. , Tawichasri C. Benets of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84907335967&origin=inward) International Journal of General Medicine. 7:411-416. 2014 citedby-count: 9 JDA
31. Chueamuangphan N. , Patumanond J. , Wongtheptien W. , Nawarawong W. ,Sukonthasarn A. , Chuncharunee S. , Tawichasri C. Benets of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84907335967&origin=inward) International Journal of General Medicine. 7:411-416. 2014 citedby-count: 9 JDA
32. Nanthatanti N. , Tantiworawit A. , Patpan N. , Rattanathammethee T. , Hantrakool S. ,Chai-Adisaksopha C. , Rattarittamrong E. , Norasetthada L. , Phrommintikul A. ,Tuntiwechapikul W. , Kumfu S. , Chattipakorn N. Telomere Length in Transfusion Dependent Thalassemia Patients BLOOD. 128. 2016 JIF : 10.452 JDA
33. Chai-Adisaksopha C. , Norasetthada L. , Tantiwora-Wit A. , Rattarittamrong E. ,Nawarawong W. The efficacy of corticosteroid monotherapy in acquired factor VIII inhibitor HAEMOPHILIA. 18:1-1. 2012 JIF : 2.364 JDA
34. Rattarittamrong E. , Luechoowong J. , Rattanathammethee T. , Chai-Adisaksopha C. ,Tantiworawit A. , Norasetthada L. Clinical manifestations and outcomes of primary systemic AL amyloidosis: Chiang Mai University Experience CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 19:E328-E329. 2019 JIF : 2.308
35. Rattarittamrong E. , Norasetthada L. , Tantiworawit A. , Chai-Adisaksopha C. ,Hantrakool S. , Rattanathammethee T. , Charoenkwan P. Acute non-atherosclerotic ST-segment elevation myocardial infarction in an adolescent with concurrent hemoglobin H-Constant Spring disease and polycythemia vera
(https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942243377&origin=inward) Hematology Reports. 7:66-69. 2015 citedby-count: 5 JDA
36. Yanika Jindamai• Ekarat Rattarittamrong• Arintaya Phrommintikul • Lalita Yongsmith •
Pokpong Piriyakhuntorn • Thanawat Rattanathammethee • Sasinee Hantrakool • Chatree Chai‐Adisaksopha • Adisak Tantiworawit • Lalita Norasetthada. Prevalence and risk factors of high echocardiographic probability
of pulmonary hypertension in myeloproliferative neoplasms patients. International Journal of Hematology https://doi.org/10.1007/s12185-020-02952-4
37. Sorasak Makmettakul1,2, Adisak Tantiworawit1* , Arintaya Phrommintikul3 , Pokpong Piriyakhuntorn1 , Thanawat Rattanathammethee1 , Sasinee Hantrakool1 , Chatree Chai-Adisaksopha1 , Ekarat Rattarittamrong1 , Lalita Norasetthada1 , Kanda Fanhchaksai4 , Pimlak Charoenkwan4 and Suree Lekawanvijit. Cardiorenal syndrome in thalassemia patients. BMC Nephrology (2020) 21:325
ร่วมงานวิจัยในระดับนานาชาติ
1. Nakamae H. , Kirby K. , Sandmaier B. , Norasetthada L. , Maloney D. , Maris M. , Davis C. , Corey L. , Storb R. , Boeckh M. Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=67349284294&origin=inward) Biology of Blood and Marrow Transplantation. 15:694-703. 2009 JIF : 3.797 citedby-count: 53 AOI
2. Rezvani A. , Norasetthada L. , Gooley T. , Sorror M. , Bouvier M. , Sahebi F. , Agura E. ,Chauncey T. , Maziarz R. , Maris M. , Shizuru J. , Bruno B. , Bredeson C. , Lange T. ,Yeager A. , Sandmaier B. , Storb R. , Maloney D. Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: A multicentre experience (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=54049140486&origin=inward) British Journal of Haematology. 143:395-403. 2008 JIF : 4.498 citedby-count: 77 AOI
3. Domenica Cappellini M. , Viprakasit V. , Taher A.T. , Georgiev P. , Kuo K.H.M. , Coates T. , Voskaridou E. , Liew H.K. , Pazgal-Kobrowski I. , Forni G.L. , Perrotta S. , Khelif A. ,Lal A. , Kattamis A. , Vlachaki E. , Origa R. , Aydinok Y. , Bejaoui M. , Joy Ho P. , Chew L.P. , Bee P.C. , Lim S.M. , Lu M.Y. , Tantiworawit A. , Ganeva P. , Gercheva L. , Shah F. , Neufeld E.J. , Thompson A. , Laadem A. , Shetty J.K. , Zou J. , Zhang J. , Miteva D. , Zinger T. , Linde P.G. , Sherman M.L. , Hermine A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85082380437&origin=inward) New England Journal of Medicine. 382:1219-1231. 2020 JIF : 70.670 citedby-count: 1 AOI
4. Wang J. , Li J. , Tantiworawit A. , Izuka S. , Yamada S. , Hill J. , Shima Rich E. , Bahceci E. A phase III randomized study of gilteritinib versus salvage chemotherapy in FLT3 mutation-positive subjects with relapsed or refractory acute myeloid leukemia (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85081645771&origin=inward) Annals of oncology : official journal of the European Society for Medical Oncology. 29:ix92. 2018 AOI
5. Verger E. , Rattarittamrong E. , Letort G. , Raffoux E. , Cassinat B. , Kiladjian J. Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone
(https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981499475&origin=inward) Leukemia andLymphoma. 58:749-751. 2017 JIF : 3.093 citedby-count: 1 AOI
6. Chai-Adisaksopha C. , Crowther M. , Isayama T. , Lim W. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: A systematic review and meta-analysis
(https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84907662267&origin=inward) Blood. 124:2450-2458. 2014 JIF : 9.060 citedby-count: 173 AOI
7. Chai-Adisaksopha C. , Hillis C. , Monreal M. , Witt D. , Crowther M. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding: A meta-analysis
(https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84943189471&origin=inward) Thrombosis and Haemostasis. 114:819-825. 2015 JIF : 5.760 citedby-count: 36 AOI
8. Isayama T. , Chai-Adisaksopha C. , McDonald S. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: A systematic review and meta-analysis
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84939813402&origin=inward) JAMA Pediatrics. 169:731-739. 2015 citedby-count: 37 AOI
9. Chai-Adisaksopha C. , Hillis C. , Lim W. , Boonyawat K. , Moffat K. , Crowther M. Hemodialysis for the treatment of dabigatran-associated bleeding: A case report and systematic review (https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942871422&origin=inward) Journal of Thrombosis and Haemostasis. 13:1790-1798. 2015 JIF : 5.550 citedby-count: 43 AOI
10. Chai-Adisaksopha C. , Hillis C. , Isayama T. , Lim W. , Iorio A. , Crowther M. Mortality outcomes in patients receiving direct oral anticoagulants: A systematic review and meta-analysis of randomized controlled trials (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84946550723&origin=inward) Journal of Thrombosis and Haemostasis. 13:2012-2020. 2015 JIF : 5.550 citedby-count: 65 AOI
11. Samuelson B. , Chai-Adisaksopha C. , Garcia D. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84942500070&origin=inward) Journal of Thrombosis and Thrombolysis. 40:474-479. 2015 JIF : 2.039 citedby-count: 6 AOI
12. Samuelson B. , Vesely S. , Chai-Adisaksopha C. , Scott B. , Crowther M. , Garcia D. The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: A meta-analysis (https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84947104333&origin=inward) Blood Coagulation and Fibrinolysis. 27:648-652. 2016 JIF : 1.403 citedby-count: 17 AOI
13. Chai-Adisaksopha C. , Thorlund K. , Iorio A. Interpreting trial sequential analysis
(https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85003253400&origin=inward) Transfusion. 56:2918-2922. 2016 JIF : 3.225 citedby-count: 1 AOI
14. Chai-Adisaksopha C. , Lam W. , Hillis C. Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A meta-analysis(https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84944929798&origin=inward) Leukemia and Lymphoma. 57:1300-1310. 2016 JIF : 2.891 citedby-count: 42 AOI
15. Li G. , Holbrook A. , Jin Y. , Zhang Y. , Levine M. , Mbuagbaw L. , Witt D. , Crowther M. , Connolly S. , Chai-Adisaksopha C. , Wan Z. , Cheng J. , Thabane L. Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=84976501524&origin=inward) European Journal of Epidemiology. 31:541-561. 2016 JIF : 5.339 citedby-count: 11 AOI
16. Tantiworawit A. , Power M. , Barnett M. , Hogge D. , Nantel S. , Nevill T. , Shepherd J. ,Song K. , Sutherland H. , Toze C. , Abou-Mourad Y. , Narayanan S. , Broady R. , Forrest D. Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84862728693&origin=inward) Leukemia and Lymphoma. 53:1321-1326. 2012 JIF : 2.492 citedby-count: 9 AOI
17. Chai-Adisaksopha C. , Brown J. FCR achieves long-term durable remissions in patients with IGHV-mutated CLL (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85034832329&origin=inward) Blood. 130:2278-2282. 2017 JIF : 11.847 citedby-count: 13 AOI
18. Chai-Adisaksopha C. , Linkins L. , Alkindi S. , Cheah M. , Crowther M. , Iorio A.Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85014315951&origin=inward) Thrombosis and Haemostasis. 117:589-594. 2017 JIF : 5.255 citedby-count: 3 AOI
19. Chai-Adisaksopha C. , Hillis C. , Siegal D. , Movilla R. , Heddle N. , Iorio A. , Crowther M. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal: A systematic review and meta-analysis
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84994667137&origin=inward) Thrombosis and Haemostasis. 116:879-890. 2016 JIF : 4.984 citedby-count: 48 AOI
20. Chornenki NJ. , Chai-Adisaksopha C. , Um K. , Mendoza P. , Samienezhad A. , Swarup V. , Siegal D. Risk of venous and arterial thrombosis in patients receiving tranexamic acid: A systematic review and meta-analysis THROMBOSIS RESEARCH. 170:2-2. 2018 JIF : 2.650
21. Boonyawat K. , Caron F. , Li A. , Chai-Adisaksopha C. , Lim W. , Alfonso I. , Lopes RD. ,Garcia DA. , Crowther M. Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis BLOOD. 128. 2016 JIF :10.452
22. Chai-Adisaksopha C. , Crowther M. , Iorio A. , Martin-Antoran M. , Lopez-Montes L. ,Morales MD. , Pons I. , Ciammaichella M. , Martin-Martos F. , Monreal M. OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS HAEMATOLOGICA. 100:20-20. 2015 JIF : 5.868 citedby-count: 1
23. Tan D. , Lee J. , Chen W. , Shimizu K. , Hou J. , Suzuki K. , Nawarawong W. , Huang S. ,Sang Chim C. , Kim K. , Kumar L. , Malhotra P. , Chng W. , Durie B. Recent advances in the management of multiple myeloma: clinical impact based on resource-strati cation. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop (https://www.scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=85041618920&origin=inward) Leukemia and Lymphoma. 59:2305-2317. 2018 JIF : 2.755 citedby-count: 6 AOI
24. Jaeger U. , Trneny M. , Melzer H. , Praxmarer M. , Nawarawong W. , Yehuda D. ,Goldstein D. , Mihaljevic B. , Ilhan O. , Ballova V. , Hedenus M. , Hsiao L. , Au W. ,Burgstaller S. , Weidinger G. , Keil F. , Dittrich C. , Skrabs C. , Klingler A. , Chott A. ,Fridrik M. , Greil R. Rituximab maintenance for patients with aggressive B-cell lymphoma inrst remission: Results of the randomized NHL13 trial
(https://www.scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84936160629&origin=inward) Haematologica. 100:955-963. 2015 JIF : 5.868 citedby-count: 42 AOI
25. Norasetthada L. , Kirby K. , Sandmaier B. , Maloney D. , Maris M. , Davis C. , Corey L. ,Storb R. , Boeckh M. CMV infection and disease after nonmyeloablative (NM) HCT revisited: Incidence, risk factors, ganciclovir-related neutropenia and outcome. BLOOD. 106:907A-908A. 2005 JIF : 10.120
26. M.D. Cappellini, V. Viprakasit, A.T. Taher, P. Georgiev, K.H.M. Kuo, T. Coates, E. Voskaridou, H.-K. Liew, I. Pazgal-Kobrowski, G.L. Forni, S. Perrotta, A. Khelif, A. Lal, A. Kattamis, E. Vlachaki, R. Origa, Y. Aydinok, M. Bejaoui, P.J. Ho, L.-P. Chew, P.-C. Bee, S.-M. Lim, M.-Y. Lu, A. Tantiworawit, P. Ganeva, et al. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. N Engl J Med 2020;382:1219-31. DOI: 10.1056/NEJMoa1910182
3. งานบริการวิชาการแก่ชุมชน สังคมและกิจกรรม corporate social responsibility (CSR) อื่น ๆ
โครงการงานโลหิตวิทยาพบประชาชน
หลักการและเหตุผล
โรคทางโลหิตวิทยาเป็นโรคที่พบบ่อยและมีแนวโน้มที่จะมีจำนวนเพิ่มขึ้นทุกปีโรคนี้พบในทุกเพศทุกวัย ซึ่งแต่ละโรคจะมีการรักษา การตอบสนองต่อการรักษา การพยากรณ์โรคที่แตกต่างกันในปัจจุบันการรักษาโรคทางโลหิตวิทยามีการพัฒนาไปมาก มีสูตรยาใหม่ๆ มากมาย สามารถแบ่งได้เป็นโรคมะเร็ง เช่น มะเร็งต่อมน้ำเหลือง มะเร็งเม็ดเลือดขาวเฉียบพลันและเรื้อรัง และโรคที่ไม่ใช่มะเร็งทางโลหิตวิทยา เช่น ภาวะหลอดเลือดดำอุดตัน เป็นภาวะแทรกซ้อนที่สำคัญพบได้บ่อยในผู้ป่วยมะเร็งทางโลหิตวิทยา และผู้ป่วยที่ไม่ใช่มะเร็ง ที่เข้ารับการรักษาในโรงพยาบาล
วัตถุประสงค์
1. เพื่อให้ประชาชนและผู้ป่วยเข้าใจเรื่องโรคทางโลหิตวิทยาที่พบบ่อย
2. เพื่อให้ประชาชน และผู้ป่วยเข้าใจถึงแนวการรักษาโรคทางโลหิตวิทยาที่พบบ่อย
3. เพื่อให้ผู้ป่วยมีความเข้าใจถึงแนวทางการปฏิบัติตัวเมื่อเข้ารับการรักษา
ระยะเวลาดำเนินงาน จัดงานภายในคณะแพทยศาสตร์ โดย
1. จัดนิทรรศการสัปดาห์โรคทางโลหิตวิทยา
2. จัดเสวนาให้ความรู้
กลุ่มเป้าหมาย บุคลากรทางการแพทย์ที่สนใจ ผู้ป่วยและญาติผู้ป่วยทางโลหิตวิทยา ประชาชนทั่วไป
ผลที่คาดว่าจะได้รับ
1. ผู้เข้ารับการอบรม มีความรู้ความเข้าใจเกี่ยวกับโรคทางโลหิตวิทยามากขึ้น
2. ผู้เข้ารับการอบรม มีความเข้าใจถึงแนวการรักษาโรคทางโลหิตวิทยาที่พบบ่อย
3. ผู้ป่วยมีความเข้าใจถึงแนวทางการปฏิบัติตัวเมื่อเข้ารับการรักษามากขึ้น
